Filing Details

Accession Number:
0001354488-12-005220
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-10-09 17:38:23
Reporting Period:
2012-10-05
Filing Date:
2012-10-09
Accepted Time:
2012-10-09 16:38:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1024126 Pernix Therapeutics Holdings Inc. PTX Pharmaceutical Preparations (2834) 330724736
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1413616 Cooper Michael Pearce 10003 Woodloch Forest Drive
#950
The Woodlands TX 77380
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-10-05 1,188 $4.20 37,855 No 4 M Direct
Common Stock Disposition 2012-10-05 1,188 $8.00 36,667 No 4 S Direct
Common Stock Acquisiton 2012-10-09 100 $4.20 36,767 No 4 M Direct
Common Stock Disposition 2012-10-09 100 $8.00 36,667 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 8/16/12.
  2. The option, which represents a right to purchase a total of 137,500 shares of which 26,388 were purchased prior to this date, became fully exercisable on 3/9/10.